celiprolol has been researched along with Hyperplasia in 1 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Celiprolol inhibited intimal hyperplasia of carotid interposition-reversed jugular vein grafts 4 weeks after implantation (Intima/media index of celiprolol group, 0." | 3.74 | Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production. ( Banno, H; Hattori, K; Itoh, T; Kajikuri, J; Kobayashi, M; Komori, K; Yamamoto, K; Yamanouchi, D, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hattori, K | 1 |
| Yamanouchi, D | 1 |
| Banno, H | 1 |
| Kobayashi, M | 1 |
| Yamamoto, K | 1 |
| Kajikuri, J | 1 |
| Itoh, T | 1 |
| Komori, K | 1 |
1 other study available for celiprolol and Hyperplasia
| Article | Year |
|---|---|
Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production.
Topics: Adrenergic beta-Antagonists; Animals; Carotid Arteries; Celiprolol; Cell Proliferation; Graft Surviv | 2007 |